Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Search Results

Your search results for {cas}

Hierarchy Filter

  • Castanospermine, 99%

    CAS: 79831-76-8

    [79831-76-8], C8H15NO4, F.W. 189.21, Solid, m.p. 213-217°, BRN 3588654, MDL MFCD00017555, TSCA No

    Hazard Codes: H302-H312-H332

    Precautionary Codes: P261-P264b-P270-P271-P280-P302+P352-P304+P340-P312-P330-P363-P403-P501c

    Saul et al. Studies on the mechanism of castanospermine inhibition of α- and β-glucosidases. Arch.Biochem.Biophys. 1984, 230,(2), 668-75.

    Gruters et al. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987, 330,(6143), 74-7.

    Structure image
  • Casein Peptone

    CAS: 91079-40-2

    [91079-40-2], EINECS 293-428-4, MDL MFCD00131829, TSCA No

    Frohnert, A.; Kreißel, K.; Lipp, P.; Dizer, H.; Hambsch, B.; Szewzyk, R.; Selinka, H. C. Removal of Surrogate Bacteriophages and Enteric Viruses from Seeded Environmental Waters Using a Semi-technical Ultrafiltration Unit. Food. Enviorn. Virol. 2015, 7 (2), 173-182.

    Baltierra-Trejo, E.; Sánchez-Yáñez, J. M.; Buenrostro-Delgado, O.; Márquez-Benavides, L. Production of short-chain fatty acids from the biodegradation of wheat straw lignin by Aspergillus fumigatus. Bioresour. Technol. 2015, 196, 418-425.

    Structure image
  • Caspase-1 Inhibitor II

    CAS: 178603-78-6

    [178603-78-6], C24H33ClN4O8, F.W. 540.99, Powder, RTECS AY3079566, MDL MFCD00237124, TSCA No

    Structure image
  • Caspase-3/7 Inhibitor

    C14H16N2O5S, F.W. 324.35, Powder, MDL MFCD22581511, TSCA No

    Structure image
  • Caspase-3 Substrate V, fluorogenic

    C60H75N14O21S, F.W. 1360.38, Lyophilized powder, MDL MFCD25541471, TSCA No

    Structure image
  • Casein, Hammarsten Grade

    CAS: 9000-71-9

    [9000-71-9], Powder, EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    A.A.Elfagm; J.V.Wheelock. Heat interaction between α-lactalbumin, β-lactoglobulin and casein in bovine milk. Journal of Dairy Science. 1978, 61,(2), 159-163.

     

    B.Tarodo De La Fuente. Solvation of casein in bovine milk. Journal of Dairy Science. 1975, 58,(3), 293-300.

    Structure image
  • Casein, tech.

    CAS: 9000-71-9

    [9000-71-9], m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519500, MDL MFCD00081481, TSCA Yes

    Irshad, I.; Kanekanian, A.; Peters, A.; Masud, T. Antioxidant activity of bioactive peptides derived from bovine casein hydrolysate fractions. J. Food Sci. Technol. 2015, 52 (1), 231-239.

    Sharma, A. K.; Sawhney, I. K. Modelling moisture sorption characteristics in dried acid casein using connectionist paradigm vis-à-vis classical methods. J. Food Sci. Technol. 2015, 52 (1), 151-160.

    Structure image
  • Castor oil

    CAS: 8001-79-4

    [8001-79-4], b.p. 313°, f.p. 230°(446°F), d. 0.961, n20/D 1.4780, EINECS 232-293-8, RTECS FI4100000, MDL MFCD00130746, TSCA Yes

    Gurunathan, T.; Mohanty, S.; Nayak, S. K. Isocyanate terminated castor oil-based polyurethane prepolymer: Synthesis and characterization. Prog. Org. Coat. 2015, 80, 39-48.

    Saez-Bastante, J.; Pinzi, S.; Jimenez-Romero, F. J.; de Castro, M. D. L.; Priego-Capote, F.; Dorado, M. P. Synthesis of biodiesel from castor oil: Silent versus sonicated methylation and energy studies. Energy Convers. Manage. 2015, 96, 561-567.

    Structure image
  • Caspase-1 Inhibitor I

    CAS: 143313-51-3

    [143313-51-3], C23H32N4O8, F.W. 492.52, Powder, MDL MFCD00237123, TSCA No

    Structure image
  • Caspase-2 Substrate, chromogenic

    C31H43N9O14, F.W. 765.72, Lyophilized powder, MDL MFCD07780993, TSCA No

    Structure image
  • Casein blocking buffer, 3% in TBS

    Liquid, MDL MFCD01634587, TSCA Yes

    R.A.Wirtz; F.Zavala; Y.Charoenvit; G.H.Campbell; T.R.Burkot; I.Schneider; K.M.Esser; R.L.Beaudoin; R.G.Andre. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ. 1987, 65,(1), 39-45.

     

    Georg Widera; Melissa Austin; Dietmar Rabussay; Cheryl Goldbeck; Susan W.Barnett; Minchao Chen; Louisa Leung; Gillis R.Otten; Kent Thudium; Mark J.Selby; Jeffrey B.Ulmer. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. The Journal of Immunology. 2000, 164,(9), 4635-4640.

    Structure image
  • Caspase-3 Inhibitor III

    CAS: 285570-60-7

    [285570-60-7], C21H31ClN4O11, F.W. 550.94, Powder, MDL MFCD01323001, TSCA No

    Structure image
  • Casein blocking buffer, 3% in PBS

    Viscous liquid, MDL MFCD01634587, TSCA Yes

    Udai Banerji; Anne O'Donnell; Michelle Scurr; Simon Pacey; Sarah Stapleton; Yasmin Asad; Laura Simmons; Alison Maloney; Florence Raynaud; Maeli Campbell; Michael Walton; Sunil Lakhani; Stanley Kaye; Paul Workman and Ian Judson. Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies. Journal Of clinical Oncology. 2005, 23 (18), 4152-4161.

    Greg Welder; Issam Zineh; Michael A. Pacanowski; Jason S. Troutt; Guoqing Cao and Robert J. Konrad. High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol. The Journal of Lipid Research. 2010, 51, 2714-2721.

    Structure image
  • Caspase-3 Substrate III, fluorogenic

    CAS: 189696-20-6

    [189696-20-6], C50H62N10O22, F.W. 1155.08, Lyophilized powder, MDL MFCD00798785, TSCA No

    Structure image
  • Caspase-1 Inhibitor IV

    CAS: 154674-81-4

    [154674-81-4], C33H42N4O10, F.W. 654.71, Powder, MDL MFCD00798794, TSCA No

    Structure image
  • Casein blocking buffer, 3% in PBS, with 0.02% sodium azide

    Liquid, MDL MFCD01634587, TSCA Yes

    Structure image
  • Caspase-9 Inhibitor III

    CAS: 403848-57-7

    [403848-57-7], C24H35ClN6O9, F.W. 587.02, Powder, MDL MFCD02259690, TSCA No

    Structure image
  • Casein Kinase II Substrate

    C52H87N19O24, F.W. 1362.38, Solid, MDL MFCD00080103, TSCA No

    Structure image
  • Caspase-7 Substrate I, fluorogenic

    C60H74N14O21, F.W. 1327.31, Lyophilized powder, MDL MFCD25372010, TSCA No

    Structure image
  • Casein hydrolysate, enzymatic digest, Ultrapure, Thermo Scientific

    CAS: 65072-00-6

    [65072-00-6], Powder, EINECS 265-363-1, MDL MFCD00282824, TSCA Yes

    Structure image
  • Casein sodium salt

    CAS: 9005-46-3

    [9005-46-3], Powder, RTECS FI3540000, MDL MFCD00130736, TSCA Yes

    François Chevalier; Alan L Kelly. Proteomic quantification of disulfide-linked polymers in raw and heated bovine milk. Journal of Agricultural and Food Chemistry. 2010, 58, (12), 7437-7444.

    K L Houseknecht; D E Bauman; D G Fox; D F Smith. Abomasal infusion of casein enhances nitrogen retention in somatotropin-treated steers. Journal of Nutrition. 1992, 122, (8), 1717-1725.

    Structure image
  • Casein, high nitrogen, 95%

    CAS: 9000-71-9

    [9000-71-9], Powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Structure image
  • Caspase-8 Inhibitor I, cell permeable

    C95H162N20O26, F.W. 2000.41, Lyophilized powder, MDL MFCD25372008, TSCA No

    Structure image
  • Caspase-3 Inhibitor I, cell permeable

    C94H158N20O27, F.W. 2000.37, Lyophilized powder, MDL MFCD08703605, TSCA No

    Structure image
  • Casein, Hammarsten, Ultrapure, Thermo Scientific

    CAS: 9000-71-9

    [9000-71-9], Lyophilized powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Hammerstein, O. Textbook of physiological chemistry, 7th ed; J. Wiley: New York, 1915; p. 652.

    Structure image
  • Casein, high nitrogen, Ultrapure, Thermo Scientific

    CAS: 9000-71-9

    [9000-71-9], Powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Structure image
  • Casein blocking buffer, 3% in TBS, with 0.02% sodium azide

    Liquid, MDL MFCD01634587, TSCA Yes

    Structure image
  • beta-Casomorphin (1-5), bovine

    CAS: 72122-63-5

    [72122-63-5], C30H37N5O7, F.W. 579.64, Solid, MDL MFCD00076332, TSCA No

    Structure image
  • beta-Casomorphin (1-5), amide, bovine

    CAS: 83936-21-4

    [83936-21-4], C30H38N6O6, F.W. 578.66, Solid, MDL MFCD00076333, TSCA No

    Structure image
  • beta-Casomorphin (1-4), amide, bovine

    CAS: 74135-04-9

    [74135-04-9], C28H35N5O5, F.W. 521.61, Solid, MDL MFCD00076328, TSCA No

    Structure image
  • alpha-Casein (90-95)

    CAS: 83471-50-5

    [83471-50-5], C38H57N9O9, F.W. 783.93, Solid, MDL MFCD00076691, TSCA No

    Structure image
  • beta-Casomorphin (1-3)

    CAS: 72122-59-9

    [72122-59-9], C23H27N3O5, F.W. 425.48, Solid, MDL MFCD00038820, TSCA No

    Structure image
  • beta-Casomorphin (1-4), bovine

    CAS: 74171-19-0

    [74171-19-0], C28H34N4O6, F.W. 522.59, Solid, MDL MFCD00076327, TSCA No

    Structure image
  • beta-Casomorphin (1-6), bovine

    CAS: 77434-43-6

    [77434-43-6], C35H44N6O8, F.W. 676.76, Lyophilized powder, MDL MFCD00076343, TSCA No

    Structure image
  • beta-Casomorphin, human, 95+%

    CAS: 102029-74-3

    [102029-74-3], C44H61N7O11, F.W. 864.01, Powder, MDL MFCD00076324, TSCA No

    Structure image
  • beta-Casomorphin (1-3), amide

    C23H28N4O4, F.W. 424.49, Solid, MDL MFCD00076325, TSCA No

    Structure image
  • 8-Carboxynaphthalene-1-carboxamide, tech. 85%

    CAS: 5811-88-1

    [5811-88-1], C12H9NO3, F.W. 215.21, m.p. 265-270°, BRN 2213597, MDL MFCD00052020, TSCA No

    Hazard Codes: H315-H319-H335

    Precautionary Codes: P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501c

    Structure image
  • Calcium D-gluconate monohydrate, 98+%

    CAS: 66905-23-5

    [66905-23-5], C12H22CaO14•H2O, F.W. 448.40 (430.37anhy), m.p. ca 195° dec., EINECS 206-075-8, RTECS EW2100000, MDL MFCD00064209, TSCA Yes

    Panagiotopoulos,N.C.; Jeffrey, G.A.; La Placa, S.J.; Hamilton, W.C. The crystal structures of the A and B forms of potassium D-gluconate monohydrate by neutron diffraction. Acta Cryst. 1974, 30, 1421-1430.

    Martina Vavrusova.; Merete Bogelund Munk.; Leif H. Skibsted. Aqueous Solubility of Calcium l-Lactate, Calcium d-Gluconate, and Calcium d-Lactobionate: Importance of Complex Formation for Solubility Increase by Hydroxycarboxylate Mixture. J. Agric. Food Chem. 2013, 61, (34), 8207-8214.

    Structure image
  • Calcium glycerophosphate hydrate, 97%

    CAS: 28917-82-0

    [28917-82-0], C3H7CaO6P•xH2O, F.W. 210.15(anhy), EINECS 249-312-0, MDL MFCD00151656, TSCA No

    Structure image
  • (1R)-(-)-Camphorquinone, 98%

    CAS: 10334-26-6

    [10334-26-6], C10H14O2, F.W. 166.22, m.p. 197-202°, BRN 2327696, MDL MFCD00082863, TSCA No

    For use in the kinetic resolution of 1,2-diols by means of diastereomeric acetal formation, see: J. Chem. Soc., Chem. Commun., 1600 (1984).

    /n

    Structure image
  • Calcium 2,4-pentanedionate hydrate, 99%

    CAS: 345909-31-1

    [345909-31-1], C10H14CaO4•xH2O, F.W. 238.30(anhy), Crystalline, m.p. 175° dec., EINECS 243-001-3, MDL MFCD00013486, TSCA Yes

    Structure image
  • Calcium fluoride crystal optic disk, 25mm x 4mm, polished both sides

    EINECS 232-188-7, MDL MFCD00010907, TSCA Yes

    Hazard Codes: H301-H332-H315-H319-H335

    Precautionary Codes: P261-P305+P351+P338-P302+P352-P321-P405-P501a

    Structure image

Chemicals

Life Science

Metals & Materials

Catalysts

Analytical & Labware